Community Health Systems
Community Health Systems, Inc. (NYSE: CYH) is a for-profit healthcare company headquartered in Franklin, Tennessee, that, through its affiliates, owns, operates, or leases 70 general acute care hospitals with over 10,000 beds across 14 states, alongside approximately 1,000 other sites of care including physician practices and urgent care centers.[1] Founded in 1985 with an initial focus on small rural hospitals, the company has expanded to serve primarily non-urban markets, emphasizing clinical services such as emergency care, inpatient treatment, and specialty programs like cancer and imaging.[2] As of mid-2025, it reports trailing twelve-month revenues of $12.6 billion, employing tens of thousands in roles supporting hospital operations and community health initiatives.[3] The organization's growth involved aggressive acquisitions, peaking after its 2014 merger with Health Management Associates, which temporarily made it the largest for-profit hospital operator in the U.S. with over 200 facilities, though subsequent divestitures reduced its footprint amid efforts to manage substantial debt loads exceeding $10 billion at times.[4] These financial pressures, coupled with operational challenges in low-margin rural settings, have defined CHS's trajectory, leading to strategic sales of underperforming assets to stabilize its balance sheet.[5] CHS has faced notable controversies, including a $60 million settlement in 2017 over allegations of unnecessary inpatient admissions and fraudulent billing practices, as well as a 2020 multi-state data breach resolution costing $5 million that exposed millions of patients' personal information.[6][7] More recently, in 2024, the U.S. Department of Justice initiated a probe into its billing practices, reflecting ongoing scrutiny of investor-owned hospitals' tendencies toward service overuse compared to nonprofit peers, per empirical analyses of claims data.[8][9] Despite these issues, the company maintains commitments to quality improvement, evidence-based care, and economic contributions as major employers in served communities.[10]Overview
Founding and Corporate Profile
Community Health Systems, Inc. (CHS) was founded in 1985 by Richard Ragsdale, who served as chairman, and E. Thomas Chaney, who became the initial CEO, with an emphasis on acquiring underperforming nonprofit hospitals in rural areas typically serving populations of 20,000 to 80,000.[11] The company was incorporated in Delaware on March 25, 1985, and completed its first hospital acquisition—Fannin Regional Hospital, a 34-bed facility in Blue Ridge, Georgia—in January 1986.[12] [11] Subsequent early purchases included Highland Medical Center in Lubbock, Texas (123 beds), and Russell County Medical Center in Lebanon, Virginia (78 beds), both in September 1986, establishing a strategy centered on revitalizing sole-provider facilities in non-urban markets.[11] Headquartered in Franklin, Tennessee, CHS operates as a for-profit, publicly traded entity on the New York Stock Exchange under the ticker symbol CYH.[2] [13] As one of the nation's largest non-urban hospital operators, it oversees approximately 70 general acute care hospitals across 14 states, along with over 1,000 affiliated sites including physician practices and urgent care centers.[2] The corporate structure supports a network delivering inpatient, outpatient, emergency, and specialty services, prioritizing accessibility in underserved regions where competitive alternatives are limited.[2] [11]
Mission and Strategic Priorities
Community Health Systems (CHS) operates with a mission to develop and operate healthcare delivery systems committed to helping people get well and live healthier, a purpose it has pursued for over 40 years across its network of general acute care hospitals and affiliated facilities.[14] This focus emphasizes providing accessible medical services in communities, particularly in non-urban areas, through a combination of inpatient and outpatient care, leveraging the company's scale to support local providers with resources for clinical improvements and technological advancements.[14] The company's strategic priorities center on enhancing operational and financial performance while prioritizing clinical quality and patient access. Key initiatives include accelerating growth in ambulatory settings, such as expanding ambulatory surgery centers (ASCs) to create new patient access points and capitalize on outpatient demand, with plans to open several facilities in 2025.[15] CHS also emphasizes standardizing operations and redesigning workflows—a multi-year project extending into early 2025—to improve efficiency and reduce costs, alongside investments in physician recruitment, facility upgrades, and advanced medical technology to bolster clinical excellence, safety, and patient experience.[16][14] These priorities align with broader efforts to refine the company's portfolio by divesting underperforming assets and concentrating resources in higher-performing markets, aiming to elevate adjusted EBITDA and same-store volumes amid ongoing industry pressures like reimbursement challenges and labor expenses.[17] In 2023, former CEO Tim Hingtgen outlined four core areas—accelerating growth, optimizing operations, improving clinical quality, and strengthening finances—to drive these outcomes, strategies that continue under interim leadership as of October 2025.[17][18]Historical Development
Inception and Rural Focus (1985–2000)
Community Health Systems was established in March 1985 by E. Thomas Chaney, Richard Ragsdale, and David Steffy, former executives from Hospital Affiliates International and Republic Health Corporation, with the initial acquisition of its first hospital occurring in May of that year.[19][11] The company's founding strategy centered on purchasing underperforming nonprofit acute-care hospitals in rural communities, typically in towns with populations between 20,000 and 80,000, where facilities often served as the sole healthcare provider and were located more than 25 miles from competitors.[11][20] This approach allowed CHS to invest capital in operational improvements, such as expanding emergency services, introducing technologies like laser surgery, and recruiting physicians to enhance clinical capabilities and financial viability.[11][20] Early expansions included the acquisition of Fannin Regional Hospital, a 34-bed facility in Blue Ridge, Georgia, in January 1986, followed by Highland Medical Center (123 beds) in Texas and Russell County Medical Center (78 beds) in Virginia that September.[11][20] By 1990, CHS had grown to operate 13 hospitals, achieving revenues of $138 million and net income of $9.3 million by 1991 through centralized management and cost efficiencies.[20] A pivotal move came in 1994 with the acquisition of Atlanta-based Hallmark Healthcare Corporation, which nearly doubled the portfolio to 18 hospitals and broadened its geographic footprint in non-urban markets across the Southeastern and Southwestern United States.[11][20][19] Leadership transitioned in 1995 when Chaney resigned as CEO, with Richard Ragsdale serving as chairman.[11] In 1996, private equity firm Forstmann Little & Company acquired CHS for $1 billion, supporting further rural hospital integrations and expanding the network to 38 facilities across 18 states.[11][20][19] Wayne T. Smith joined as president in January 1997 and was elevated to CEO in April, overseeing revenue growth to $850 million in 1998 and $1 billion in 1999, with the company operating 45 hospitals by mid-1999.[11][20][19] This period solidified CHS's emphasis on rural healthcare delivery, where approximately 85% of its markets lacked alternative acute-care providers, prior to its initial public offering in June 2000.[20]Aggressive Expansion Phase (2001–2010)
During this decade, Community Health Systems (CHS) executed a strategy centered on serial acquisitions of primarily nonprofit hospitals in non-urban areas, leveraging debt financing to scale operations rapidly. By early 2001, the company operated approximately 57 facilities, expanding through 23 acquisitions completed between 2001 and 2006, which drove a 163% increase in revenues over that span.[21] Hospital admissions grew at a compound annual rate of 21% from 2002 to 2006, reflecting integration of acquired assets and modest organic growth in existing markets.[21] This approach prioritized geographic clustering in secondary markets to capture local monopolies and enhance bargaining power with payers. A pivotal transaction occurred in 2007 when CHS acquired Triad Hospitals, Inc., for $6.8 billion in cash and stock, adding 50 hospitals across 11 states and marking the largest hospital deal of the decade.[22] The Triad integration expanded CHS into five new states and boosted licensed beds by over 6,000, aligning with the company's focus on general acute care in underserved regions.[23] Post-acquisition, CHS invested in facility upgrades and service enhancements at these sites, though integration challenges emerged due to the scale. Smaller deals supplemented growth, such as the 2005 purchase of Sunbury Community Hospital in Pennsylvania.[23] By the end of 2010, CHS had grown to 130 affiliated hospitals, up from 125 the prior year, with total licensed beds exceeding 20,000.[24] This expansion solidified CHS as one of the largest for-profit hospital operators by facility count, emphasizing operational efficiencies like centralized purchasing and revenue cycle management to offset acquisition costs.[25] The strategy, led by CEO Wayne T. Smith, relied on favorable credit markets pre-financial crisis to fund deals, though it elevated leverage ratios as debt mounted to support the buildup.[26]Restructuring Amid Challenges (2011–Present)
Following the aggressive expansion of the prior decade, Community Health Systems (CHS) encountered mounting financial pressures starting in 2011, including elevated debt levels exceeding $10 billion by mid-decade, shifts in payer reimbursements under the Affordable Care Act, and declining collectability of self-pay revenues.[27][28] These factors, compounded by operational inefficiencies in acquired facilities, led to persistent net losses and credit rating downgrades, with the company's leverage metrics straining under interest expenses.[29] A pivotal event occurred in January 2014 when CHS acquired Health Management Associates (HMA) for $7.6 billion, expanding its footprint but ballooning debt and triggering immediate integration costs that contributed to a $112 million quarterly loss in the first period post-closing.[30] The deal faced antitrust scrutiny from the Federal Trade Commission, requiring divestiture of two hospitals in Georgia and Alabama to preserve competition.[31] HMA's pre-acquisition history of qui tam lawsuits alleging improper Medicare billing practices extended regulatory risks to CHS, culminating in a $260 million Department of Justice settlement in September 2018 resolving civil claims related to unnecessary admissions from 2007 to 2014.[32] To address these strains, CHS initiated widespread divestitures and restructuring from 2015 onward, shrinking its hospital portfolio from over 200 facilities at its peak to 83 by 2021, with sales proceeds directed toward debt reduction.[33] Early efforts included spinning off non-core assets and selling dozens of underperforming hospitals amid broader industry consolidation pressures.[34] By 2018, with debt reaching $13.8 billion, CHS engaged financial advisors to explore comprehensive debt restructuring options, including potential exchanges and refinancings.[35] Subsequent years saw repeated debt refinancings to extend maturities and manage liquidity, such as 2022 transactions bolstering the balance sheet and a July 2025 refinancing of $1.79 billion in 2027 notes into longer-term 9.75% obligations due 2034.[36][37] Divestiture activity accelerated in the 2020s, with CHS targeting $1 billion in hospital sales for 2024, completing transactions like three Florida facilities to Tampa General for $294 million in December 2023, ShorePoint Health in Florida and Lake Norman Regional in North Carolina in early 2025, Cedar Park Regional in Texas in July 2025, and a Cleveland, Tennessee, hospital in August 2024.[38][39][40] A tentative agreement for three Pennsylvania hospitals to Tenor Health Foundation was announced in August 2025.[41] These moves, while reducing scale, improved adjusted EBITDA margins and supported positive net income of $130 million in Q3 2025, though leverage remained elevated at 8.1x.[42][43] CHS indicated no further major sales planned for late 2025, signaling a shift toward operational stabilization.[44]Operations
Hospital Network and Assets
Community Health Systems operates a network of 75 affiliated acute care hospitals, which its subsidiaries own or lease, as of February 2025.[45] These facilities collectively provide more than 11,000 licensed beds and serve communities primarily in non-urban areas.[45] The company's hospital portfolio emphasizes general acute care services, with a strategic focus on smaller markets where competition is limited and local demand drives utilization.[1] In addition to its core hospital assets, CHS manages over 1,000 other sites of care, encompassing physician practices, urgent care centers, freestanding emergency departments, imaging centers, and rehabilitation facilities.[45] These ancillary assets support inpatient operations by extending outpatient capabilities and enhancing revenue diversification, particularly in behavioral health and surgical services.[46] The network's structure includes both wholly owned properties and leased arrangements, allowing flexibility amid fluctuating market conditions and divestiture strategies.[45] Geographically, the hospitals span 14 states, with the highest concentrations in Florida (8 facilities), Texas (7), and Tennessee (6), reflecting a deliberate emphasis on the Southeast and Sun Belt regions.[47][48] This distribution aligns with CHS's origins in rural healthcare, where many hospitals act as the primary or sole providers in their locales, contributing to economic stability through employment and charity care.[46] Recent asset adjustments, such as sales of outreach labs and individual hospitals, have refined the portfolio to prioritize higher-performing sites while maintaining scale.[49][50]Core Services and Clinical Capabilities
Community Health Systems (CHS) operates a network of general acute care hospitals that provide essential inpatient and outpatient medical services, focusing on communities where they often serve as the primary or sole provider of such care. Core services encompass emergency room operations, which handle urgent and life-threatening conditions around the clock, and general acute care for conditions requiring short-term hospitalization and monitoring.[51] These hospitals support a broad spectrum of patient needs, including diagnostic imaging, laboratory testing, and rehabilitation therapies, enabling comprehensive treatment pathways within integrated facilities.[23] Surgical capabilities form a cornerstone of CHS's clinical offerings, with general and specialty surgery services available across its affiliated hospitals, including procedures for trauma, orthopedics, and other interventions performed in equipped operating rooms. Critical care units provide advanced monitoring and support for patients with severe illnesses or post-surgical recovery, often incorporating mechanical ventilation and hemodynamic stabilization. Obstetrics and labor/delivery services cater to maternal and neonatal care, including high-risk pregnancies, while internal medicine addresses chronic and acute non-surgical conditions.[51][12] Specialized clinical capabilities extend to oncology for cancer diagnosis and treatment, cardiology for heart-related diagnostics and interventions, and radiology for advanced imaging such as CT scans and MRIs. Outpatient facilities affiliated with CHS hospitals include ambulatory surgery centers for same-day procedures, imaging centers for non-emergent scans, urgent care centers for minor ailments, and cancer centers offering chemotherapy and radiation. Occupational medicine clinics provide work-related injury treatment and preventive services, enhancing community-level health management. These capabilities are supported by investments in medical technology and physician recruitment to maintain service quality in rural and non-urban markets.[2][52]Market Presence and Geographic Strategy
Community Health Systems (CHS) maintains a nationwide presence through ownership or operation of 70 acute-care hospitals spanning 14 states, with an emphasis on non-urban and secondary markets that feature lower levels of competition from larger academic or tertiary centers.[1][47] This footprint includes facilities in states such as Alabama, Alaska, Arizona, Florida, Georgia, Kentucky, Louisiana, Mississippi, Missouri, North Carolina, Oklahoma, Pennsylvania, Tennessee, and Texas, where the company targets communities with aging populations and limited access to specialized care.[47] The strategy prioritizes geographic diversification to mitigate risks from localized economic downturns or payer mix variations, while focusing on regions where CHS can achieve scale through clustered operations that support shared administrative efficiencies and referral networks.[53] Historically rooted in rural healthcare delivery, CHS's geographic approach evolved from early acquisitions of undercapitalized facilities in underserved areas to a more selective model post-2010, emphasizing markets with stable reimbursement dynamics and potential for outpatient expansion.[54] The company avoids dense urban corridors dominated by integrated delivery networks, instead pursuing "tuck-in" opportunities in exurban or micropolitan areas to build defensible market share without direct confrontation from high-cost competitors.[55] This positioning leverages lower operational costs in smaller markets but exposes CHS to vulnerabilities like volume fluctuations from seasonal industries or outmigration trends in rural demographics.[56] In recent years, CHS has executed a deliberate divestiture program to refine its footprint, selling off underperforming or non-core assets to streamline operations and deleverage its balance sheet toward a $1 billion target set in 2024.[38] Notable transactions include the $260 million sale of ShorePoint Health facilities in Florida to AdventHealth in late 2024, the divestiture of an 80% stake in Cedar Park Regional Medical Center in Texas in July 2025, and laboratory outreach assets across 13 states to Labcorp for $195 million in July 2025.[57][58][59] These moves have concentrated resources on higher-margin hospitals in core geographies, with leadership signaling a shift to opportunistic acquisitions in complementary markets as debt reduction progresses.[60] By Q3 2025, this recalibration has reduced exposure to volatile regions while preserving a broad but focused national platform for ambulatory and inpatient growth.[61]Financial Performance
Historical Revenue and Profit Trends
Community Health Systems experienced modest revenue growth during its formative years from 1985 to 2000, operating primarily small rural hospitals with limited scale; public financial data from this period is sparse, but the company's focus on community-based facilities laid the groundwork for later expansion without significant profitability pressures.[62] The aggressive acquisition strategy from 2001 to 2010 drove substantial revenue increases, as CHS pursued leveraged buyouts and mergers to build a larger network. Revenue rose to $3.58 billion by 2005 and further to $11.09 billion in 2010, reflecting the integration of acquired assets like regional hospital chains.[63] Net income remained positive in several years during this phase, reaching $823 million in 2009 amid favorable reimbursement environments, but shifted to a $650 million loss in 2010 due to escalating debt service costs from acquisition financing.[63] Post-2010 restructuring efforts amid regulatory scrutiny, reimbursement cuts, and high leverage led to initial revenue growth followed by contraction. Revenue peaked above $20 billion in the mid-2010s through ongoing acquisitions, but strategic divestitures of underperforming hospitals—totaling dozens of facilities since 2016—to reduce debt and streamline operations caused a sustained decline, with annual revenue falling to $12.63 billion in 2024.[64] [5] Net profits turned predominantly negative from 2011 onward, hampered by goodwill impairments, rising labor and supply costs, and interest expenses exceeding $1 billion annually in peak debt years; for instance, the company reported cumulative losses exceeding $5 billion over the decade, though trailing twelve-month net income improved to $329 million by late 2025 amid cost controls and volume recovery.[65] [66]| Year | Revenue ($B) | Net Income ($M) |
|---|---|---|
| 2005 | 3.58 | 373 |
| 2010 | 11.09 | -650 |
| 2020 | ~14.9 | Negative |
| 2024 | 12.63 | -516 |
Recent Metrics and 2020s Developments
In 2024, Community Health Systems reported full-year net operating revenues of $12.63 billion, reflecting a continuation of modest fluctuations amid asset optimization efforts.[68] For the fourth quarter specifically, revenues totaled $3.265 billion, marking a 2.6% increase from $3.181 billion in the prior-year quarter, driven by higher patient volumes and reimbursement rates.[45] Adjusted EBITDA for the year stood at levels supporting operational stability, though net income reflected periodic losses due to non-operating factors like interest expenses on substantial debt. Entering 2025, the company experienced flat overall revenue growth, with net operating revenues for the first nine months reaching $9.38 billion, a 0.1% rise from the comparable 2024 period.[69] Third-quarter 2025 revenues were $3.087 billion, essentially unchanged from $3.090 billion in the third quarter of 2024, but same-store net revenue increased by 6%, attributable to stronger admissions and improved payer mixes in core markets.[70] [71] Adjusted EBITDA rose 8.4% year-over-year in the quarter, signaling enhanced operational efficiency despite broader revenue stagnation, with full-year 2025 guidance projecting $12.4 billion to $12.6 billion in net operating revenues.[70] [68] Key developments in the 2020s have centered on navigating post-pandemic volume recovery and macroeconomic pressures. Patient utilization trends, which had supported growth earlier in the decade, reversed in the second quarter of 2025, with admissions declining due to reduced consumer confidence, financial constraints, and uncertainties around immigration policies affecting uninsured patient flows.[72] [73] This followed years of strategic divestitures—over 40 hospitals sold since 2020—to streamline operations and alleviate debt burdens exceeding $10 billion, enabling a focus on higher-performing rural and community facilities.[74] Despite these challenges, CHS emphasized same-store growth initiatives, including enhanced clinical capabilities and cost controls, positioning for potential margin expansion into 2026.[71]Debt Management and Capital Strategies
Community Health Systems has maintained a high debt load, totaling approximately $11 billion in gross debt at the start of 2025, stemming largely from leveraged acquisitions during its expansion phases in the 2000s and early 2010s. This resulted in leverage ratios exceeding 7x EBITDA initially that year, reflecting ongoing pressures from operational challenges in rural and smaller markets.[75] To mitigate refinancing risks, the company has prioritized extending debt maturities and optimizing its capital structure through targeted bond issuances and tender offers. For instance, in the second quarter of 2025, CHS issued $700 million in 10.75% senior secured notes due 2033, using proceeds to refinance shorter-term obligations and support liquidity.[76] Subsequent transactions in 2025 further advanced these efforts, including the refinancing of $1.743 billion in existing notes, which extended maturities to 2029 and contributed to a leverage reduction to 6.7x by late in the year. In August 2025, CHS completed a $1.79 billion senior secured notes offering due 2034, paired with a concurrent tender offer to retire higher-cost or nearer-term debt, effectively eliminating much of its senior unsecured obligations and addressing maturities through 2027. These moves, as rated by agencies like Fitch, improved near-term liquidity but maintained a speculative-grade profile amid persistent industry headwinds such as reimbursement pressures.[77][78][79] Complementing refinancing, CHS's capital strategies emphasize deleveraging via free cash flow allocation and divestitures of non-core assets, which generated proceeds for debt reduction and operational focus. Approximately 97% of its debt is fixed-rate as of mid-2025, limiting exposure to interest rate volatility, though the company has avoided significant equity raises in recent years to preserve shareholder control. These approaches aim to stabilize the balance sheet while funding essential investments in hospital infrastructure, though success hinges on sustained revenue growth from patient volumes and cost efficiencies.[80][81][82]Leadership and Governance
Key Executives and Transitions
Kevin Hammons serves as President and Interim Chief Executive Officer of Community Health Systems (CHS), having assumed the interim CEO role on October 1, 2025, following the retirement of the prior CEO.[83] Hammons joined CHS in 1997 and held various financial leadership positions before becoming Chief Financial Officer in January 2020, a role he maintained until September 2025.[18] Jason K. Johnson acts as Senior Vice President, Interim Chief Financial Officer, and Chief Accounting Officer, appointed to the interim CFO position effective October 1, 2025, while retaining his accounting responsibilities held since prior to that date.[84] Other senior executives include Justin D. Pitt as President, Chief Legal Counsel, Administrative Officer, and Assistant Secretary; Brad Cash as Executive Vice President of Financial Operations; Tomi Galin as Executive Vice President of Corporate Communications, Marketing, and Public Affairs; and Kevin Stockton as Executive Vice President of Operations and Development.[83] Regional operations are led by presidents such as James M. (Matt) Hayes (Interim President, Region 1), Chad Campbell (Region 2), and Mark Medley (Region 3).[83] A significant leadership transition occurred in July 2025 when Tim L. Hingtgen announced his retirement as CEO, effective September 30, 2025, after serving in that capacity since January 2021.[85] Hingtgen had previously been President and Chief Operating Officer from September 2016 to December 2020 and continued in a consulting role post-retirement, advising on healthcare operations for an annual fee of approximately $400,000.[86] This shift prompted Hammons' elevation to interim CEO and Johnson's to interim CFO, reflecting ongoing adjustments amid CHS's operational challenges.[85] Earlier, in October 2020, Wayne T. Smith transitioned from CEO to Executive Chairman, paving the way for Hingtgen's appointment as CEO in January 2021.[87] Smith had led CHS as CEO since April 1997, overseeing its expansion from a private firm with about 40 hospitals to a major for-profit operator through acquisitions, and served as Chairman from 2001 until his full retirement in December 2022.[88] These transitions underscore a pattern of internal promotions amid the company's divestitures and financial restructuring efforts since the early 2010s.[11]Board Structure and Oversight
The Board of Directors of Community Health Systems, Inc. (CHS) comprises 11 members, including a chairman and a lead independent director, with the majority qualifying as independent under applicable standards.[89][90] Wayne T. Smith serves as Chairman of the Board, while John A. Clerico acts as Lead Independent Director.[90] The board's structure emphasizes independence and expertise, with directors selected based on criteria including ethical standards, business acumen, relevant experience in healthcare or finance, and sufficient time commitment; diversity factors such as gender, race, and ethnicity are also considered in nominations.[91] The full board is elected annually by shareholders for one-year terms, with no fixed term limits, though directors must tender resignation upon material changes in occupation or following a majority "against" vote in uncontested elections.[91] Corporate governance guidelines adopted by CHS prioritize shareholder protection through transparency, internal controls, and adherence to best practices in director qualifications and committee composition.[89] The board maintains oversight of strategic direction, executive performance, financial reporting, and risk management, delegating specific functions to three standing committees: Audit and Compliance, Compensation, and Governance and Nominating.[89][91] The Audit and Compliance Committee, chaired by Michael Dinkins and comprising independent directors (four of five designated as financial experts under SEC rules), oversees financial statements, internal audits, compliance programs, risk assessment (including cybersecurity), and external auditor independence.[90][91] The Compensation Committee, led by James S. Ely, III and consisting solely of independent members, evaluates and sets executive compensation using data from independent consultants, ensuring alignment with performance metrics and incorporating a post-2023 clawback policy for incentive-based pay.[90][91] The Governance and Nominating Committee, chaired by John A. Fry, identifies and recommends director nominees, reviews governance policies, and ensures candidate pools include at least one woman or member of an underrepresented group.[90][91]| Committee | Chair | Key Responsibilities | Independence |
|---|---|---|---|
| Audit and Compliance | Michael Dinkins | Financial oversight, compliance, risk management, cybersecurity | All independent; 4/5 financial experts[91] |
| Compensation | James S. Ely, III | Executive pay design, performance alignment, clawback enforcement | All independent[91] |
| Governance and Nominating | John A. Fry | Director nominations, governance reviews, diversity considerations | All independent[91] |